Electra Therapeutics Insider Trades
NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 4 · $40.00M
- Sales
- 0 · $0
- Shares bought / sold
- 2.67M / 0
- Net activity
- Net buying $40.0 million
Electra Therapeutics insider activity
Over the last 12 months, Electra Therapeutics insiders reported 16 transactions on SEC Form 4: 4 open-market purchases and 0 sales. Insiders bought $40.0 million and sold $0 worth of stock, for net insider buying of $40.0 million. The most recent filing shows ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLC (Director) reporting a transaction in 2,002,310 shares on Sep 21, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ETRA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ETRA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 21, 2026 | Koe Gary S.Chief Technical Officer | Conversion | 63,656 | — | Form 4 |
| Sep 21, 2026 | Dong Quehuong (Kathy)President & CEO | Conversion | 455,484 | — | Form 4 |
| Sep 21, 2026 | Parry GrahamChief Scientific Officer | Conversion | 85,504 | — | Form 4 |
| Sep 21, 2026 | Stagliano NancyDirector | Conversion | 255,635 | — | Form 4 |
| Sep 21, 2026 | GORDON CARL LDirector | Buy | 1,000,000 | $15.00M | Form 4 |
| Sep 21, 2026 | GORDON CARL LDirector | Conversion | 758,279 | — | Form 4 |
| Sep 21, 2026 | GORDON CARL LDirector | Buy | 333,333 | $5.00M | Form 4 |
| Sep 21, 2026 | GORDON CARL LDirector | Conversion | 1,703,314 | — | Form 4 |
| Sep 21, 2026 | GORDON CARL LDirector | Conversion | 1,087,934 | — | Form 4 |
| Sep 21, 2026 | GORDON CARL LDirector | Conversion | 2,002,310 | — | Form 4 |
| Sep 21, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Buy | 1,000,000 | $15.00M | Form 4 |
| Sep 21, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Conversion | 758,279 | — | Form 4 |
| Sep 21, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Buy | 333,333 | $5.00M | Form 4 |
| Sep 21, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Conversion | 1,703,314 | — | Form 4 |
| Sep 21, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Conversion | 1,087,934 | — | Form 4 |
| Sep 21, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Genesis GP LLCDirector | Conversion | 2,002,310 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4